RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Gonzalez-McQuire, S. [1 ]
Hensen, M. [2 ]
Spoorendonk, J. [2 ]
Alleman, C. [2 ]
机构：
[1] Amgen Europe GmbH, Zug, Switzerland
[2] Pharmerit BV, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2407
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY23
引用
收藏
页码：A662 / A662
页数：1
相关论文
共 50 条
  • [21] Clinical characteristics and outcomes of Black patients with multiple myeloma compared with other races
    Spence, Shelli
    Yu, Junhua
    Girvan, Allicia
    Ng, Sophia
    Li, Sophia
    Zafar, Faiza
    Yellow-Duke, Archibong
    Cornell, R. Frank
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [22] Vertebroplasty in multiple myeloma: Outcomes in a large patient series
    McDonald, R. J.
    Trout, A. T.
    Gray, L. A.
    Dispenzieri, A.
    Thielen, K. R.
    Kallmes, D. F.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (04) : 642 - 648
  • [23] Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma
    Yan, Xiaoyu
    Clemens, Pamela L.
    Puchalski, Thomas
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Usmani, Saad
    Richardson, Paul G.
    Plesner, Torben
    Liu, Kevin
    Orlowski, Robert Z.
    Losic, Nedjad
    Jansson, Richard
    Ahmadi, Tahamtan
    Lantz, Kristen
    Ruixo, Juan Jose Perez
    Zhou, Honghui
    Xu, Xu Steven
    CLINICAL PHARMACOKINETICS, 2018, 57 (04) : 529 - 538
  • [24] Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma
    Xiaoyu Yan
    Pamela L. Clemens
    Thomas Puchalski
    Sagar Lonial
    Henk Lokhorst
    Peter M. Voorhees
    Saad Usmani
    Paul G. Richardson
    Torben Plesner
    Kevin Liu
    Robert Z. Orlowski
    Nedjad Losic
    Richard Jansson
    Tahamtan Ahmadi
    Kristen Lantz
    Juan Jose Perez Ruixo
    Honghui Zhou
    Xu Steven Xu
    Clinical Pharmacokinetics, 2018, 57 : 529 - 538
  • [25] Real-World Multiple Myeloma Treatment Patterns By Patient Characteristics and Outcomes in the United States
    Richter, Joshua
    Singh, Erin
    Rice, Megan S.
    BLOOD, 2021, 138
  • [26] RELATIONSHIP BETWEEN CIRCULATING BAFF LEVELS WITH PROLIFERATION MARKERS IN PATIENTS WITH MULTIPLE MYELOMA
    Tsirakis, G.
    Fragioudaki, M.
    Boula, A.
    Spanoudakis, M.
    Kaparou, M.
    Kanellou, P.
    Papadakis, I.
    Alegakis, A.
    Pappa, C.
    Alexandrakis, M.
    HAEMATOLOGICA, 2012, 97 : 337 - 338
  • [27] The Study of Relationship Between Multiple Myeloma and Some Trace Elements in Iraqi Patients
    Mohammed, Abdulameer Jasim
    Gate, Abbas Mohsin
    MACROMOLECULAR SYMPOSIA, 2022, 401 (01)
  • [28] The relationship between symptoms and patient characteristics among psoriasis patients
    Bilac, Cemal
    Ermertcan, Aylin Tuerel
    Bilac, Dilek Bayraktar
    Deveci, Artuner
    Horasan, Goenuel Dinc
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2009, 75 (05):
  • [29] Empowering Multiple Myeloma Patients: Impact of MMRF Education Programs and Results Of Patient Outcomes
    Bohorquez-Medd, Veronica
    DeRome, Mary
    Young, Anne Quinn
    LaTemple, Denise
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S102 - S103
  • [30] Retrospective Analysis of Characteristics and Outcomes for Multiple Myeloma in Colombia
    Sossa-Melo, Claudia
    Abello, Virginia
    Pena, Angela
    Salazar, Luis
    Rosales, Manuel
    Chen, Xueyi
    Luna-Gonzalez, Maria
    Ochoa, Miguel
    Espinosa, Daniel
    Casas, Claudia
    Solano, Maria H.
    Chalela, Claudia M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S312 - S312
12345